First CRISPR Clinical Trial Sponsored By US Companies Launches.

STAT (8/31, Begley) reported the first clinical trial of a CRISPR-Cas9 sponsored by US companies “has launched, testing the genome-editing technique in patients with the blood disorder beta thalassemia.” According to STAT, the “Phase 1/2 clinical trial,...